Production (Stage)
China Pharma Holdings, Inc.
CPHI
$1.90
$0.0633.42%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.20% | 3.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.20% | 3.07% | |||
| Cost of Revenue | -1.72% | -20.08% | |||
| Gross Profit | 15.26% | 69.09% | |||
| SG&A Expenses | -42.70% | 116.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.67% | 6.62% | |||
| Operating Income | 36.57% | -10.20% | |||
| Income Before Tax | 35.84% | -9.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 35.84% | -9.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 35.84% | -9.53% | |||
| EBIT | 36.57% | -10.20% | |||
| EBITDA | 42.61% | -92.63% | |||
| EPS Basic | 54.62% | 17.85% | |||
| Normalized Basic EPS | 54.63% | 17.84% | |||
| EPS Diluted | 54.62% | 17.85% | |||
| Normalized Diluted EPS | 54.63% | 17.84% | |||
| Average Basic Shares Outstanding | 41.36% | 33.33% | |||
| Average Diluted Shares Outstanding | 41.36% | 33.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||